http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3950713-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13dff6a3f7b26356582ff2bcee722a3c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2019-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9e61e5c7faa632a290aceb4b17736e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83f4111d543ec23f515d92b2f05fec2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e4d05960e4cf3ddb77b2af2b1eb3ab8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d04d487fa7ed1ef0b2c8a2f6bc8214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3feafe2dca64a889f69775af967ae5a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5916107d48f8e374e2790de70385b10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb81de9d5effa286dadbaec66c85a44d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e483b52bebd65b1bb539db8408d018a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_138fbf84a81feddf170e338526c971d2
publicationDate 2022-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3950713-A1
titleOfInvention Fusion protein comprising anti-mesothelin antibody, anti-cd3 antibody or anti-egfr antibody, bispecific or trispecific antibody comprising same, and uses thereof
abstract The present invention relates to: a fusion protein comprising a fragment of an anti-mesothelin antibody, an anti-CD3 antibody or an anti-EGFR antibody; a bispecific antibody that is specific to mesothelin and CD3; a trispecific antibody that is specific to mesothelin, CD3 and EGFR; and uses thereof. The bispecific or trispecific antibody according to the present invention can be prepared in a high yield and with high purity, and has excellent tumor killing and growth inhibitory effects, and thus can be effectively used in cancer treatment.
priorityDate 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466867542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930

Total number of triples: 47.